Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 10:44 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 145–168 of 589 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: SIGNAL Clear all

Conditions: General Menstrual Discomfort
Interventions: Jovi Patch, Sham Patch; Device
Lead sponsor: Signal Relief; Industry
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Meadowbrook, Pennsylvania

Conditions: IgG4 Related Disease, IgG4-RD
Interventions: elotuzumab, placebo for elotuzumab, methylprednisolone, diphenhydramine, acetaminophen, famotidine, prednisone; Drug
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years to 70 Years
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 3
States / cities: Atlanta, Georgia • Boston, Massachusetts • Rochester, Minnesota

Conditions: Uveal Melanoma
Interventions: Selumetinib, 100mg, Selumetinib, 125mg, Selumetinib, 150mg, Selumetinib, 175mg, Selumetinib, 200mg, Selumetinib, 225mg; Drug
Lead sponsor: Shaheer A. Khan; Other
Eligibility: 18 Years and older
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 3
States / cities: New York, New York • Houston, Texas

Conditions: Neoplasm Metastasis
Interventions: CC-90003; Drug
Lead sponsor: Celgene; Industry
Eligibility: 18 Years and older
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 4
States / cities: Los Angeles, California • New Haven, Connecticut • Charlotte, North Carolina + 1 more

Conditions: Alcohol Abuse
Interventions: Alcohol, Saline; Drug
Lead sponsor: Mark Fillmore; Other
Eligibility: 21 Years to 29 Years
Enrollment: 28 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Lexington, Kentucky

Conditions: Alzheimer Disease
Interventions: flortaucipir F18, Brain PET Scan; Drug · Procedure
Lead sponsor: Avid Radiopharmaceuticals; Industry
Eligibility: 55 Years to 85 Years
Enrollment: 205 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Lung Cancer
Interventions: Erlotinib, Satraplatin; Drug
Lead sponsor: Agennix; Industry
Eligibility: 70 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2009
U.S. locations: 11
States / cities: Anaheim, California • La Jolla, California • Los Angeles, California + 8 more

Conditions: Intracranial Embolism, Cerebral Thromboembolism, Carotid Stenosis
Interventions: ARC1779 Injection, Placebo (normal saline); Drug
Lead sponsor: Archemix Corp.; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 2
States / cities: Hackensack, New Jersey • Houston, Texas

Conditions: Stroke, Motor Activity
Interventions: GAITRite assessment; Device
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 21 Years to 65 Years
Enrollment: 21 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Medication Adherence
Interventions: Vitality GlowCaps; Device
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years and older
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Thoracic Epidural Anesthesia
Interventions: Traditional (loss-of-resistance technique) thoracic epidural placement, CompuFlo thoracic epidural placement; Device
Lead sponsor: YATISH SIDDAPURA RANGANATH; Other
Eligibility: 18 Years to 70 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Clinical Stage T2b or Less of Prostate Cancer, Prostate Brachytherapy, Transrectal Prostate Ultrasound Treatment Planning
Interventions: An ultrasound-based technique to identify prostate cancer, pre-implant transrectal ultrasound images and planning, ultrasound-based cancer-specific images; Other
Lead sponsor: Beth Israel Medical Center; Other
Eligibility: 18 Years and older · Male only
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2014
U.S. locations: 1
States / cities: New York, New York

Conditions: Speech, Hearing Loss, Sensorineural, Hearing Aids
Interventions: Tympan; Device
Lead sponsor: Indiana University; Other
Eligibility: 18 Years to 65 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Bloomington, Indiana

Conditions: Healthy Volunteers
Interventions: ID-Capsule- Active, Wearable Sensor; Device
Lead sponsor: EtectRX, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 13 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Inflammatory Bowel Diseases
Interventions: ECG recording, inflammatory cytokines, microbiota, ulcerative colitis disease activity index; Other
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Other Reconstructive Surgery
Interventions: Sham PEMF Device, Ivivi Torino II PEMF Device; Device
Lead sponsor: Columbia University; Other
Eligibility: 18 Years to 85 Years · Female only
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2014
U.S. locations: 1
States / cities: New York, New York

Conditions: Arrhythmia, Cardiac
Interventions: recorded patients; Other
Lead sponsor: NewPace Ltd; Industry
Eligibility: Not listed
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Atlantis, Florida

Conditions: Spinal Cord Injuries, Pain, Neuropathic
Interventions: Alpha-Stim M; Device
Lead sponsor: SCI Research Advancement; Other
Eligibility: Not listed
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019
U.S. locations: 1
States / cities: Buellton, California

Conditions: Tourette Syndrome in Adolescence
Interventions: Neurofeedback from the SMA, Neurofeedback from control region; Other
Lead sponsor: Yale University; Other
Eligibility: 10 Years to 16 Years
Enrollment: 64 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Obsessive-Compulsive Disorder, Tricholemmoma, Skin-Picking
Interventions: Computerized cognitive training, Computerized placebo training; Behavioral
Lead sponsor: University of Wisconsin, Milwaukee; Other
Eligibility: 18 Years to 60 Years
Enrollment: 118 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Healthy, Pain
Interventions: Selective Nerve Stimulation (SNS) stimulator device; Device
Lead sponsor: Codman & Shurtleff; Industry
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: Raynham, Massachusetts

Conditions: Parkinson Disease, Essential Tremor, Dystonia, Obsessive Compulsive Disorder
Interventions: Functional Magnetic Resonance Imaging (fMRI); Procedure
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 90 Years
Enrollment: 88 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2017
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Hearing Impairment
Interventions: Sound amplification provided via EarLens System.; Device
Lead sponsor: EarLens Corporation; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 3
States / cities: Menlo Park, California • San Jose, California • Iowa City, Iowa

Conditions: COVID-19, Upper Respiratory Infection, Lower Respiratory Infection
Interventions: Fitbit, Douglas Bag, Periflux 6000 EPOS, BIOPAC, Flowmet, NIRS; Device
Lead sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); NIH
Eligibility: 18 Years to 78 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Bethesda, Maryland

Search by objective public record fields.

A Study of the Jovi Patch, Powered by Signal Relief, for the Improvement of General Menstrual Discomfort

Elotuzumab in Immunoglobulin G4-Related Disease (IgG4-RD)

Intermittent Selumetinib for Uveal Melanoma

Safety and PK Study of CC-90003 in Relapsed/Refractory Solid Tumors

Sex Differences in Risk for Alcohol Abuse

Evaluation of Flortaucipir PET Signal and Cognitive Change in Early Alzheimer's Disease

A Study Comparing Sequential Satraplatin & Erlotinib to Erlotinib in Unresectable Stage 3/4 Non-small-cell Lung Cancer (NSCLC)

Effect of ARC1779 on Cerebral Microembolism in Patients Undergoing Carotid Endarterectomy

Gait Mate: Examining Neural Networks Engaged During Lower Extremity Movement in the MRI

Medication Adherence in Kidney Transplant Recipients Using Automated Reminders and Provider Notification

CompuFlo Thoracic Epidural Study

Using Ultrasound Spectrum Analysis (USA) to Guide Dose Escalated Prostate Brachytherapy

Effects of Nonlinear Signal Processing Algorithms on Speech Perception

Performance of the ID-Cap System, an Ingestion Event Marker, in the Clinical Setting as an Aid to Measure Medication Adherence

Autonomic and Cytokines Profiles of Patients With Ulcerative Proctitis

Use of Pulsed Electromagnetic Fields (PEMF) After Breast Reconstruction Surgery

Surface Electrocardiogram (ECG) Signal Recording for Implantable Subcutaneous String Defibrillator (ISSD) Development

Using NI-ES to Treat Spinal Cord Injury (SCI)

Neurofeedback From the Supplementary Motor Area for Tourette Syndrome

Neural Mechanisms of Response Inhibition Training for OCRD

Selective Nerve Stimulation (SNS) Pilot Study

Functional Magnetic Resonance Imaging (fMRI) During Deep Brain Stimulation (DBS) to Treat Parkinson's Disease

The EarLens System Long Term Safety and Efficacy Definitive Multi-Center Study

A Noninvasive Multimodal Biosensing Device for Screening and Monitoring Response to Treatment of Infectious Respiratory Diseases